Mirova’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Buy |
2,909
+1,766
| +155% | +$138K | 0.03% | 110 |
|
|
2025
Q1 | $82.8K | Hold |
1,143
| – | – | 0.01% | 126 |
|
|
2024
Q4 | $84.6K | Sell |
1,143
-5,296
| -82% | -$392K | 0.01% | 122 |
|
|
2024
Q3 | $425K | Hold |
6,439
| – | – | 0.07% | 97 |
|
|
2024
Q2 | $595K | Hold |
6,439
| – | – | 0.11% | 86 |
|
|
2024
Q1 | $615K | Buy |
6,439
+5,248
| +441% | +$501K | 0.11% | 78 |
|
|
2023
Q4 | $90.8K | Sell |
1,191
-72
| -6% | -$5.49K | 0.02% | 105 |
|
|
2023
Q3 | $87.5K | Sell |
1,263
-2,348
| -65% | -$163K | 0.02% | 107 |
|
|
2023
Q2 | $341K | Sell |
3,611
-4,045
| -53% | -$382K | 0.06% | 104 |
|
|
2023
Q1 | $633K | Buy |
7,656
+4,792
| +167% | +$396K | 0.09% | 99 |
|
|
2022
Q4 | $214K | Sell |
2,864
-2,154
| -43% | -$161K | 0.03% | 156 |
|
|
2022
Q3 | $414K | Sell |
5,018
-14,608
| -74% | -$1.21M | 0.07% | 127 |
|
|
2022
Q2 | $1.87M | Buy |
19,626
+16,268
| +484% | +$1.55M | 0.27% | 65 |
|
|
2022
Q1 | $395K | Sell |
3,358
-69
| -2% | -$8.12K | 0.05% | 131 |
|
|
2021
Q4 | $443K | Sell |
3,427
-2,084
| -38% | -$269K | 0.05% | 123 |
|
|
2021
Q3 | $623K | Buy |
5,511
+486
| +10% | +$54.9K | 0.08% | 107 |
|
|
2021
Q2 | $520K | Sell |
5,025
-353
| -7% | -$36.5K | 0.06% | 108 |
|
|
2021
Q1 | $449K | Buy |
5,378
+868
| +19% | +$72.5K | 0.05% | 108 |
|
|
2020
Q4 | $411K | Buy |
4,510
+4,028
| +836% | +$367K | 0.05% | 95 |
|
|
2020
Q3 | $38K | Buy |
482
+368
| +323% | +$29K | 0.01% | 140 |
|
|
2020
Q2 | $8K | Hold |
114
| – | – | ﹤0.01% | 163 |
|
|
2020
Q1 | $7K | Hold |
114
| – | – | ﹤0.01% | 163 |
|
|
2019
Q4 | $9K | Buy |
+114
| New | +$9K | ﹤0.01% | 165 |
|